This attack does 30 more damage for each different type of Pokémon on your Bench.
If this Pokémon was healed during this turn, this attack does 80 more damage.
Release year for BREAKthrough is 2015. BREAKthrough is grouped under the XY era.
With 165 listed cards, this is a mid-size set by modern TCG standards. As of 2026, the set is 11 years old and now falls into an established back-catalog period.
In the BREAKthrough checklist, Xerneas occupies position #107 as a Rare Holo card.
Xerneas is a BREAKthrough card from the 2015 release window. The printed flavor text states: "When the horns on its head shine in seven different colors, it is said to be sharing everlasting life." Core profile: Its card type is Pokémon.
The rarity label is Rare Holo. Printed HP is 120.
Energy typing is Fairy. It carries a Basic subtype designation.
Notable move text references "Rainbow Force" and "Power Creation". It has a weakness to Metal and resistance to Darkness.
Latest market snapshots place Xerneas in BREAKthrough at roughly $0.62. Its 7-day movement is largely flat at 0.0%.
Current value is elevated versus the 30-day mean ($0.60), by 4.1%. The 90-day window shows a floor near $0.50 and a peak around $0.62 (19% total spread), which maps to low-volatility movement.
The listed rarity for this print is Rare Holo.
Collectors tracking Xerneas often benchmark it against other Xerneas cards. The current sample spans 6 comparable cards from 5 sets.
Comparable prices currently cover $0.11-$8.06, a 7227% band. Against the sample mean of $2.08, this card is -70%.
Notable alternatives include Xerneas #XY31 (XY Black Star Promos) at $2.42, Xerneas #XY05 (XY Black Star Promos) at $8.06, Xerneas #81 (Steam Siege) at $0.69, and Xerneas #96 (XY) at $0.86.
Pricing context for collectors: Over the last 7 days, prices have remained stable at 0.0%, indicating a consolidation phase over sudden breakouts. With a 19% 90-day spread ($0.50-$0.62), this card currently tracks as low-volatility.
Current value is 4.1% above its 30-day reference ($0.60). Condition sensitivity is substantial: PSA 10 carries a +10384% premium over raw value.
PSA 9 is currently around $14.00, while PSA 10 is $65.00.
